Clinical Trial Update: Allogeneic Human Mesenchymal Stem Cell Infusion for Frailty Patient [NA]

View source ↗

Summary

This document reports the completion of a clinical trial evaluating allogeneic human mesenchymal stem cell infusion for frailty in older adults, sponsored by Da…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frailty in Older Adults

Drugs mentioned

• Allogeneic human mesenchymal stem cell infusion (mesenchymal stem cells (allogeneic))

Snippet

Sponsor: Daewoong Group Indonesia | Conditions: Frailty in Older Adults | NA | Status: COMPLETED